NextCure (NXTC) Earnings Date & Reports

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NXTC is expected to report earnings to rise 8.97% to -42 cents per share on July 31

Q2'25

Est.

$-0.43

Q1'25

Missed

by $0.01

Q4'24

Missed

by $0.08

Q3'24

Missed

by $0.06

Q2'24

Missed

by $0.17

The last earnings report on May 01 showed earnings per share of -38 cents, missing the estimate of -37 cents. With 512.37K shares outstanding, the current market capitalization sits at 10.80M.

View a ticker or compare two or three

Compare

NXTC